The Russian vaccine was launched in August and a Lancet study reported that it is safe and it induces Antibody in early limited trials. The Russian vaccine is named Sputnik V, after the Soviet-era space programme. On august 11, Russia became the first country in the world to develop a vaccine against the severe acute respiratory syndrome due to corona virus. The vaccine is developed with two adenovirus which was developed by the Gamaleya National Center of Epidemiology and Microbiology (Moscow, Russia)